Phcog.Net logo

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Article

    LC-MS-Based Phytochemical Profiling of Priyangvadi choorna and its Correlation with Hemostatic Activity

    Adithya Anil Bams1, Santosh Yallappa Mudakappagol1, Raj Joshi1 Corresponding author

    1. 1Department of Shalyatantra, Shri BMK Ayurveda Mahavidyalaya Postgraduate Studies and Research Centre, A Constituent Unit of KLE Academy of Higher Education and Research Centre (Deemed to be University), Belagavi, Karnataka, INDIA.

    CORRESPONDENCE

    Santosh Yallappa Mudakappagol

    Professor, Department of Shalyatantra, Shri BMK Ayurveda Mahavidyalaya Postgraduate Studies and Research Centre, A Constituent Unit of KLE Academy of Higher Education and Research Centre (Deemed to be University), Belagavi-590003, Karnataka, INDIA.

    drmysantosh@gmail.com

    Received: 14-12-2025; Revised: 08-02-2026; Accepted: 27-04-2026.

    Volume 18, Issue 3 · pp. 883–889 · PUBLISHED Jul-Sep 2026 · DOI: 10.5530/pres.20260260

    View on Pharmacogn. Res. original site ↗

    ABSTRACT

    Background Priyangvadi Churna is a traditional indigenous Ayurvedic Polyherbal formulation explained in the treatment of bleeding disorders (Raktapitta) by Yogaratnakar. In spite of its renowned efficacy in standard Ayurvedic textbooks, there is a deficiency of phytochemical representation to back its hemostatic qualities through existing analytical procedures. Objectives To identify and illustrate bioactive elements of Priyangvadi Churna using LC-MS and their applicability to hemostatic activity. Materials and Methods Methanolic extracts of Priyangvadi Churna were tested with a Waters 1525 µ Binary Pump LC system and a Waters Xevo G2-XS QT of mass spectrometer. Results A total of 454 distinct phyto-constituents were documented, 223 are unknown. These includes flavonoids, tannins, Alkaloids, etc, were consistent with Ayurvedic therapeutic actions like Raktasthambhaka (blood-stopping) and Shothahara (anti-inflammatory). Conclusion The LC-MS profile of Priyangvadi Churna justifies its classical use as a hemostatic agent. Identified bioactive compounds show pharmacological potential for clotting enhancement and vascular integrity.

    KEYWORDS

    0% READ

    FULL TEXT

    INTRODUCTION

    Bleeding is one of the important global health concerns. The commonest causes are injuries, surgeries, obstetrics, and pathological disorders. Traumatic bleeding is the leading cause of preventable death, contributing to nearly 40% of global mortality in early trauma (Watson et al., 2022). Non-cardiac perioperative bleeding accounts for approximately 11.6% of cases within 30 days following surgery (Alderliesten et al., 2024). Globally, bleeding significantly increases the duration of hospital stay and healthcare expenditure and adversely affects clinical outcomes (Leff et al., 2020).

    Despite advances in hemostatic management, both local and systemic agents are currently in use with notable limitations. Local hemostatic agents may interfere with wound healing and increase the risk of infection (Achneck et al., 2010; Spotnitz and Burks, 2012). Systemic agents, such as antifibrinolytics, are associated with adverse effects including thromboembolic events, hypersensitivity reactions, and renal complications, particularly in susceptible individuals (Ker et al., 2012; Levi and Hunt, 2015). These challenges emphasize the need for safer, targeted, and biocompatible alternatives, including plant-derived and polyherbal hemostatic formulations.

    In Ayurveda, Raktasthambhanopāyas (haemostatic measures) are described in the management of Raktātīpravṛtti (excessive bleeding) and include therapeutic principles such as Sandhāna, Skandhana, Pācana, and Dāhana (Sharma, 2001). Among the formulations employed under Sandhāna therapy, Priyangvadi Choorna is a traditional polyherbal preparation indicated for various bleeding disorders such as epistaxis, oral bleeding, anorectal bleeding, vaginal bleeding, penile bleeding, and wounds caused by sharp instruments, as documented in Yogaratnakara (Shastri, 2010).

    The formulation is reported to possess hemostatic, anti-inflammatory, antimicrobial, and wound-healing properties (Sharma et al., 2001; Shastri, 2010). Priyangvadi Choorna is traditionally administered using classical Ayurvedic methods, often with Vasa swarasa. The present work represents the first application of Liquid Chromatography-Mass Spectrometry (LC-MS) for chemical profiling of this formulation. LC-MS analysis revealed the presence of multiple phytoconstituents known for their anti-inflammatory, antioxidant, and cytoprotective activities.

    MATERIALS AND METHODS

    Priyangvadi Choorna was obtained from GMP Certified Ayurveda pharmacy Khasbag, Belgavi, mentioned in Table 1 (Government of India, Department of AYUSH, 2003) and analysed using LC-MS by standard protocols.

    Table 1: List of Ingredients Used in the Formulation of Priyangvadi Choorna.
    DrugLatin nameFamilyPart used
    PriyanguCallicarpa macrophyllaVerbanaceflower
    LodraSymplocos recemosasymplococeaeRoot bark
    VasaAdathoda vasicaacanthaceaeleaves
    Shodhitha SphatikaPottash alum-Powdered form of whole mineral drug
    RasanjanaBerberis aristataBerberidaceaeRhizome

    Study conduction

    Our study was conducted in Biocyte Research and Development Pvt. Ltd., Sangli, Maharashtra.

    Simple Preparation

    After purchasing Priyangvadi Choornam in powdered form, 100 mg of the sample was precisely weighed and diluted in 100 mL of methanol. To ensure full extraction of phytochemical contents, the solution underwent sonication for 20 min. After sonication, the solution was filtered to produce an extract clear enough for LC-MS analysis. Analysis of Liquid Chromatography-Mass Spectrometry (LC-MS) was conducted utilizing a Waters Xevo G2-XS QT mass spectrometer alongside a Waters 1525 µ Binary Pump liquid chromatography system. Chromatographic separation was carried out using an Accucore C18 column (50 mm × 4.6 mm, 5 µm particle size; ThermoScientific). The mobile phases consisted of Acetonitrile (solvent B) and 0.1% formic acid in water (solvent A). The gradient elution schedule used was: 95% A and 5% B from 0 to 1 min, transitioning to 50% A and 50% B by 8 min, moving to 5% A and 95% B by 12 min, maintained until 17 min, then returning to 95% A and 5% B by 18 min, which remained until 20 min. Throughout the run, the injection volume stayed at 10 µL, and the flow rate was held steady at 0.5 mL/min.

    Mass Spectrometry Parameters

    The mass spectrometer functioned in positive and negative Electrospray Ionization (ESI) modes to detect each component present. The collision energy was configured to 20 V, and the capillary voltage was adjusted to 3.0 kV. The collision energy could range from 30 to 90 V. The temperatures for the source and desolvation were held constant at 150°C and 450°C, respectively. The gas flow rate for desolvation was 800 L/h, whereas the cone gas flow rate stood at 50 L/h. Data Gathering Information was obtained using MassLynx software (version 4.1). For analyzing the chemical composition of the plant sample, both positive and negative ionization modes can be used to produce Total Ion Chromatograms (TIC) and Base Peak Intensity (BPI) chromatograms.

    Ethical Statement

    Not applicable, as this study involved an in vitro phytochemical analysis of a commercial product. No human or animal subjects were used.

    Statistical Analysis

    Because the study concentrated on analytical profiling without assessing differences between groups, inferential statistical approaches were not applicable.

    RESULTS

    The LC-MS analysis of Priyangvadi Choorna was performed in both negative and positive ionization modes. Figure 1 shows the negative mode LC-TIC and BPI chromatograms, while Figure 2 depicts the positive mode LC-TIC and BPI chromatograms. The analysis revealed the presence of multiple bioactive phytochemicals, including flavonoids (Tectochrysin, Kaempferol, Liquiritigenin, Hesperetin, Ononin), alkaloids (Sanguinarine), phenolic acids (Ellagic acid, 1,3-Benzenedicarboxylic acid), and other compounds such as Thalidomide and 4-Methylumbelliferone.

    Figure 1: Negative mode LC-TIC and BPI Chromatograms.
    Figure 2: Positive mode LC - TIC and BPI Chromatograms.

    Several of these constituents, including Ellagic acid, Hesperetin, Sanguinarine, and Tectochrysin, have been reported to modulate platelet activation, thrombus formation, and vascular health. Ellagic acid acts as a haemostatic agent by activating Factor XII in the intrinsic coagulation pathway. Sanguinarine modulates the GPVI signaling pathway and regulates thromboxane, thereby controlling platelet activation. Hesperetin and Tectochrysin inhibit platelet aggregation and inflammation, helping maintain endothelial stability and preventing thrombosis. Additionally, 4-Methylumbelliferone (4-MU) and Biochanin A exert antioxidant and anti-inflammatory effects, contributing to vascular protection and maintaining haemostatic balance.

    These findings support the traditional use of Priyangvadi Choorna in wound healing and bleeding management. Table 2 summarizes the phytocomponents detected in the acetone-extracted Priyangvadi Choorna by LC-MS, highlighting their potential role in modulating platelet function, stabilizing the endothelium, and maintaining haemostatic equilibrium.

    Table 2: Phytocomponents detected in the acetone-extracted Priynvadi choorna using LC-MS.
    Compound NameRT (min)Precursor m/zAreaIon Mode
    Tectochrysin5.247267.063329053673Negative
    Constrictic acid4.843447.056247490154Negative
    Liquiritigenin6.507279.059021190501Positive
    4-methylumbelliferone1.052198.91307934112Positive
    Sanguinarine1.204332.09515348657Positive
    Liquiritigenin8.225279.0556169946Positive
    Hesperetin4.84303.19116152093Positive
    5-Methoxytryptamine5.649191.116593424Positive
    Phenazone4.537189.1016591635Positive
    Biochanin A7.366285.1710587158Positive
    Ononin4.487453.1202778514Positive
    Thalidomide5.245259.0705347245Positive
    1,3-Benzenedicarboxylic acid1.205165.0191745886Negative
    Kaempferol-7-O-glucoside5.247447.0952142224Negative
    L-Tryptophan5.8205.0971833407Positive
    Coumarin base + 1O, 1MeO1.205191.0349,406,799Negative
    Ellagic acid4.84303.01357,638,887Positive
    Laxapur4.287239.03524,923,317Negative
    Khellin6.305261.0811,571,245Positive
    Table 3: Pharmacological Activity of Compounds Found in LCMS of Priynvadi Choorna.
    CompoundMolecule formulaPharmacological action
    TectochrysinC16H12O4Anti-inflammatory, Anti-cancer, Anti-bacterial, Hepatoprotective and neuroprotective effects Antioxidant.
    Constrictic acidC19H14O10Antimicrobial Antioxidant 38.
    LiquiritigeninC15H12O4Anti-inflammatory, Anti-hyperlipidaemia, anti-oxidative.
    4-methylumbelliferoneC10H8O3Inflammatory responses Haemostatic function Maintaining vascular integrity.
    SanguinarineC20H14NO4Anti-inflammatory, antioxidant Antitumor. Platelet activation.
    LiquiritigeninC15H12O4Anti-inflammatory, Anti-hyperlipidaemia, Anti-oxidative.
    HesperetinC16H14O6Antiplatelet agent.
    5-MethoxytryptamineC₁₁H₁₄N₂OAntioxidant Anti-inflammatory Neuroprotective.
    PhenazoneC11H12N2OAnalgesic Anti-inflammatory.
    Biochanin AC16H12O5Anti-inflammatory, anti-oxidant, Anti-cancer neuroprotective.
    OnoninC22H22O9Anti-inflammatory.
    ThalidomideC13H10N2O4Procoagulant activity Anti-inflammatory.
    1,3-Benzenedicarboxylic acidC8H6O4Antiinflammatory Anticancer / Antitumor Activity.
    Kaempferol-7-O-glucosideC21H20O11Anti-inflammatory, Anti-cancer, Antibacterial,
    L-TryptophanC₁₁H₁₂N₂O₂Antioxidant 40.
    Coumarin base + 1O, 1MeOImproved venous circulation, anti-neoplastic. Anticancer agents Antibacterial activities, antioxidant.
    Ellagic acidC14H6O8Anti- inflammatory Anti-oxidant Anticancer.
    LaxapurC14H8O4Antioxidant Anti -inflammatory.
    KhellinC14H12O5Anti-inflammatory antioxidant, Antimicrobial activities, Vaso dialator.

    DISCUSSION

    LC-MS (liquid chromatography-mass spectrometry) analysis identified several compounds with potential haemostatic properties, including flavonoids, alkaloids, and phenolic acids such as tectochrysin, hesperetin, kaempferol, biochanin A, 4-methylumbelliferone, ononin, columbianetin, and ellagic acid. Ellagic acid enhances coagulation by activating Hageman factor (factor XII) in the intrinsic pathway, resulting in increased serine protease activity. It is a naturally occurring polyphenolic compound and is also known for its antiproliferative, wound-healing, and antioxidant properties (Gopalakrishnan et al., 2014; Umesalma and Sudhandiran, 2011). Sanguinarine, an alkaloid belonging to the benzophenanthridine class, exhibits anti-inflammatory, antioxidant, and anticancer activities. It attenuates collagen-induced platelet activation and thrombus formation by modulating the GPVI pathway, reducing intracellular calcium mobilization and integrin αIIbβ3-mediated outside-in signaling (Shu et al., 2021). Biochanin A, an isoflavone, enhances vasorelaxation in coronary arteries and may indirectly support haemostasis by maintaining vascular tone. It also exhibits neuroprotective, anti-inflammatory, anticancer, and antioxidant properties through modulation of NF-κB, AP-1, and JAK/STAT signaling pathways (Feng and Lai, 2023; Sobotková et al., 2009). Tectochrysin, a methylated flavonoid, demonstrates antithrombotic activity by inhibiting NF-κB signaling, thereby reducing platelet aggregation and pro-inflammatory cytokine expression. Additionally, it exhibits anti-inflammatory, antibacterial, hepatoprotective, neuroprotective, and antioxidant effects (Lee et al., 2003; Lu et al., 2020). Liquiritigenin reduces oxidative stress and extracellular matrix accumulation under hyperglycaemic conditions by suppressing NF-κB and NLRP3 inflammasome activation, thereby promoting wound healing (Zhu et al., 2018). 4-Methylumbelliferone exhibits anti-inflammatory effects by regulating MAPK, SYK, and NF-κB signaling pathways. Although it does not directly influence coagulation, it helps maintain endothelial integrity, which is essential for vascular homeostasis (Wang et al., 2022). Kaempferol prevents platelet activation and thrombus formation while offering vascular protection. It also possesses anti-inflammatory, antioxidant, and anticancer activities (Lee et al., 2018; Liu et al., 2020). Ononin reduces inflammatory cytokine production by downregulating inflammatory mediator mRNA expression via inhibition of the NOD1/RIP2/NF-κB signaling pathway (Yu et al., 2023). Columbianetin exhibits significant anti-inflammatory and antioxidant effects in immune cells (Lu et al., 2018). Hesperetin, a bioflavonoid, exhibits antioxidant, anti-inflammatory, antihypertensive, antiatherogenic, and anticancer properties. It reduces oxidative stress, DNA damage, and cellular apoptosis by modulating p38 MAPK, NF-κB, and caspase-3 signaling pathways, thereby reducing doxorubicin-induced cardiotoxicity (Rehman et al., 2024). Thalidomide exhibits procoagulant effects under specific conditions by increasing tissue factor expression and thrombin generation in endothelial cells and also possesses anti-inflammatory and anti-angiogenic properties (Akter et al., 2022; Chen et al., 2009; Qiao et al., 2017). Isophthalic acid (1,3-benzenedicarboxylic acid) exhibits antibacterial and antifungal activities (Hamsalakshmi et al., 2021). Coumarins are naturally occurring compounds with diverse biological properties, including antibacterial, anti-inflammatory, and anticancer activities (Garrard, 2014; Lake, 1999; Önder, 2020). Laxapur, a flavonoid compound, acts as a potent free-radical scavenger and exerts anti-inflammatory effects by inhibiting NF-κB signaling and reducing pro-inflammatory mediators such as iNOS and COX-2 (Egbuna et al., 2020; Lin et al., 2009). Khellin is primarily known for its vasodilatory and smooth muscle relaxant properties (National Center for Biotechnology Information [NCBI], 2025a). Constictic acid, a lichen-derived depsidone, exhibits antimicrobial and antioxidant activities (NCBI, 2025b). Antipyrine, a pyrazolone derivative, exhibits analgesic, antipyretic, anti-inflammatory, and platelet-inhibitory effects through inhibition of cyclooxygenase-mediated prostaglandin synthesis (NCBI, 2025c). Tryptophan, an essential amino acid, serves as a precursor for bioactive molecules such as melatonin and kynurenine, contributing to antioxidant and immunomodulatory effects (Ghazaghi et al., 2024). 5-Methoxytryptamine, a serotonin derivative, exhibits free-radical scavenging activity and suppresses inflammation via cytokine modulation (NCBI, 2025d; Tan et al., 1993).

    CONCLUSION

    A detailed phytochemical investigation of Priyangvadi Choorna through LC-MS analysis revealed the presence of 454 compounds, among them 223 are unknown molecules which may exhibit coagulative properties. The known compounds, particularly those associated with haemostasis, inflammatory control, and wound healing. Principal ingredients, including Ellagic acid, Sanguinarine, Hesperetin, Tectochrysin, and Liquiritigenin, indicated established functions in augmenting coagulation pathways and maintaining endothelial integrity. No sufficient study has been conducted for particularly for haemostatic activity in many compounds found in Priyangvadi Choorna. These results illustrate that the traditional usage of Priyangvadi Choorna is a treatment for bleeding disorders, inflammatory diseases, and wound healing issues. The findings further underscore its promise as a natural, plant-derived treatment for the development of innovative haemostatic medicines.

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

    1. 1.Achneck, H. E.; Sileshi, B.; Jamiolkowski, R. M.; Albala, D. M.; Shapiro, M. L.; Lawson, J. H.. A comprehensive review of topical hemostatic agents. Annals of Surgery. 2010;251(2):217–228. https://doi.org/10.1097/SLA.0b013e3181cb5a6dDOIGOOGLE SCHOLAR
    2. 2.Akter, R.; Khan, S. S.; Kabir, M. T.; Halder, S.. GC-MS-employed phytochemical characterization and antioxidant potential of Triphala extract. Saudi Journal of Biological Sciences. 2022;29(6):103287. https://doi.org/10.1016/j.sjbs.2022.103287DOIGOOGLE SCHOLAR
    3. 3.Alderliesten, T.; de Jonge, S. W.; Boermeester, M. A.; van der Velde, S.; Tollenaar, R. A. E. M.; Dijkgraaf, M. G. W.. Timing and incidence of major postoperative bleeding after non-cardiac surgery: A multicentre cohort study. The Lancet Regional Health - Europe. 2024;33:100686. https://doi.org/10.1016/j.lanepe.2024.100686DOIGOOGLE SCHOLAR
    4. 4.Chen, C.; Kuehn, C.; Bretzel, R. G.; Linn, T.. Anti-inflammatory thalidomide improves islet graft survival. PLOS ONE. 2009;4(7):e6312. https://doi.org/10.1371/journal.pone.0006312DOIGOOGLE SCHOLAR
    5. 5.Feng, Z.-J.; Lai, W.-F.. Chemical and biological properties of biochanin A. Pharmaceutics. 2023;15(4):1105. https://doi.org/10.3390/pharmaceutics15041105DOIGOOGLE SCHOLAR
    6. 6.Garrard, A.. Coumarins. Encyclopedia of toxicology. 3. Academic Press. 2014;1052–1054.GOOGLE SCHOLAR
    7. 7.Ghazaghi, M.; Asghari-Moghadam, M.; Mehri, M.. Immunoregulatory and antioxidant properties of tryptophan. Heliyon. 2024;10(8):e29115. https://doi.org/10.1016/j.heliyon.2024.e29115DOIGOOGLE SCHOLAR
    8. 8.Gopalakrishnan, L.; Ramana, L. N.; Sethuraman, S.; Krishnan, U. M.. Ellagic acid-encapsulated chitosan nanoparticles as anti-hemorrhagic agents. Carbohydrate Polymers. 2014;111:215–221. https://doi.org/10.1016/j.carbpol.2014.03.093DOIGOOGLE SCHOLAR
    9. 9.Ker, K.; Edwards, P.; Perel, P.; Shakur, H.; Roberts, I.. Effect of tranexamic acid on surgical bleeding: Systematic review and cumulative meta-analysis. BMJ. 2012;344:e3054. https://doi.org/10.1136/bmj.e3054DOIGOOGLE SCHOLAR
    10. 10.Lake, B. G.. Coumarin metabolism, toxicity and carcinogenicity. Food and Chemical Toxicology. 1999;37(4):423–453.GOOGLE SCHOLAR
    11. 11.Lee, S.; Kim, K. S.; Park, Y.; Shin, K. H.; Kim, B. K.. In vivo antioxidant activities of tectochrysin. Archives of Pharmacal Research. 2003;26(1):43–46.GOOGLE SCHOLAR
    12. 12.Leff, J.; Downs, S.; Spahn, D. R.. Management of major bleeding and coagulopathy following trauma: An update. The Lancet. 2020;396(10245):1235–1246. https://doi.org/10.1016/S0140-6736(20DOIGOOGLE SCHOLAR
    13. 13.Levi, M.; Hunt, B. J.. A critical appraisal of tranexamic acid use in bleeding trauma patients. Journal of Thrombosis and Haemostasis. 2015;13(9):1910–1922. https://doi.org/10.1111/jth.13113DOIGOOGLE SCHOLAR
    14. 14.Lu, J.; Fang, K.; Wang, S. et al. Anti-inflammatory effect of columbianetin. Mediators of Inflammation. 2018;2018:9191743. https://doi.org/10.1155/2018/9191743DOIGOOGLE SCHOLAR
    15. 15.Lu, M.; Tan, L.; Zhou, X. et al. Tectochrysin extends lifespan via FOXO/DAF-16. Biogerontology. 2020;21(5):669–682.GOOGLE SCHOLAR
    16. 16.National Center for Biotechnology Information. PubChem compound summary for khellin (CID 3828). PubChem. 2025a.GOOGLE SCHOLAR
    17. 17.National Center for Biotechnology Information. PubChem compound summary for constictic acid (CID 71436827). PubChem. 2025b.GOOGLE SCHOLAR
    18. 18.National Center for Biotechnology Information. PubChem compound summary for antipyrine (CID 2206). PubChem. 2025c.GOOGLE SCHOLAR
    19. 19.National Center for Biotechnology Information. PubChem compound summary for 5-methoxytryptamine (CID 1833). PubChem. 2025d.GOOGLE SCHOLAR
    20. 20.Sharma, P. C.; Yelne, M. B.; Dennis, T. J.. Database on medicinal plants used in Ayurveda (Vol. 2). Central Council for Research in Ayurveda and Siddha. 2001.GOOGLE SCHOLAR
    21. 21.Sharma, P. V.. Sushruta Samhita: With English translation of text and Dalhana’s commentary. Chaukhambha Vishvabharati. 2001.GOOGLE SCHOLAR
    22. 22.Shastri, L.. Yogaratnakara. Chaukhambha Sanskrit Sansthan. 2010.GOOGLE SCHOLAR
    23. 23.Shu, D.; Zhu, Y.; Lu, M. et al. Sanguinarine attenuates platelet activation. Biomedicines. 2021;9(5):444. https://doi.org/10.3390/biomedicines9050444DOIGOOGLE SCHOLAR
    24. 24.Spotnitz, W. D.; Burks, S.. Hemostats, sealants, and adhesives: Components of the surgical toolbox. Transfusion. 2012;52(1 Suppl):10S–19S. https://doi.org/10.1111/j.1537-2995.2012.03707.xDOIGOOGLE SCHOLAR
    25. 25.Tan, D.-X.; Chen, L. D.; Poeggeler, B.; Manchester, L. C.; Reiter, R. J.. Melatonin: A potent endogenous hydroxyl radical scavenger. Endocrine Journal. 1993;1:57–60.GOOGLE SCHOLAR
    26. 26.Umesalma, S.; Sudhandiran, G.. Ellagic acid prevents colon carcinogenesis. European Journal of Pharmacology. 2011;660(2-3):249–258.GOOGLE SCHOLAR
    27. 27.Watson, J. N.; Moore, L. J.; Wade, C. E.; Holcomb, J. B.. Bleeding, hemorrhagic shock, and the global blood supply. Current Trauma Reports. 2022;8(2):67–74. https://doi.org/10.1007/s40719-022-00221-3DOIGOOGLE SCHOLAR
    28. 28.Yu, T.; Lu, X.; Liang, Y. et al. Ononin alleviates DSS-induced colitis. Immunity, Inflammation and Disease. 2023;11:e776. https://doi.org/10.1002/iid3.776DOIGOOGLE SCHOLAR

    Cite this article

    SELECT FORMAT

    Bams, A. A., Mudakappagol, S. Y., & Joshi, R. (2026). LC-MS-Based Phytochemical Profiling of Priyangvadi choorna and its Correlation with Hemostatic Activity. Pharmacognosy Research, 18(3), 883–889. https://doi.org/10.5530/pres.20260260